DM programs take advantage of new therapies to reduce costs, complications for MS patients.
Multiple sclerosis patients can benefit from new drugs that slow the progression of the disease, but only a fraction (20%) actually receive these drugs. A specialty DM firm has found a way to enhance medication management and assist patients in keeping debilitating complications at bay.
D003363:Cost Control; D019468:Disease Management; D006801:Humans; D008329:Managed Care Programs; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics; D009657:North Carolina; D010348:Patient Care Team; D010349:Patient Compliance; D017410:Practice Guidelines as Topic